Hepatocellular Neoplasm-Not Otherwise Specified (HCN-NOS)
Showing 1 - 25 of >10,000
Hepatoblastoma, Hepatocellular Carcinoma (HCC), Liver Tumors Trial in Boston (ET140203 T Cells)
Recruiting
- Hepatoblastoma
- +5 more
- ET140203 T Cells
-
Boston, MassachusettsDana-Farber/Boston Children's Cancer and Blood Disorders Center
Aug 12, 2022
Refractory T-Cell Lymphoma, Relapsed T-Cell Lymphoma Trial in Italy (Daratumumab)
Active, not recruiting
- Refractory T-Cell Lymphoma
- Relapsed T-Cell Lymphoma
-
Bari, Italy
- +6 more
Aug 1, 2022
T-Cell Lymphoma Relapsed, T-Cell Lymphoma Refractory Trial in Italy (Venetoclax)
Active, not recruiting
- T-Cell Lymphoma Relapsed
- T-Cell Lymphoma Refractory
-
Aviano, Italy
- +12 more
Dec 20, 2022
Peripheral T Cell Lymphoma, PTCL, Extranodal NK/T-cell Lymphoma Trial in Worldwide (Tislelizumab)
Completed
- Peripheral T Cell Lymphoma
- +18 more
-
Vancouver, British Columbia, Canada
- +29 more
Apr 29, 2022
Stage IV Esophageal Adenocarcinoma, Stage IV Esophageal Squamous Cell Carcinoma, Stage IV Gastric Cancer Trial in San Francisco
Recruiting
- Stage IV Esophageal Adenocarcinoma
- +43 more
- Radiation Therapy (RT)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 29, 2022
CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in
Active, not recruiting
- Central Nervous System Embryonal Tumor With Rhabdoid Features
- +14 more
- Adavosertib
- Irinotecan Hydrochloride
-
Birmingham, Alabama
- +23 more
Oct 7, 2022
Irritable Bowel Syndrome, Functional Abdominal Pain Syndrome, Child Trial in Almere, Breda, Amsterdam (Small intestinal release
Recruiting
- Irritable Bowel Syndrome
- +5 more
- Small intestinal release peppermint oil
- +2 more
-
Almere, Flevoland, Netherlands
- +2 more
Mar 22, 2023
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Stage IB3 Cervical Cancer FIGO 2018, Stage II
Recruiting
- Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified
- +13 more
- Cisplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 31, 2022
T-Cell Lymphoma, Peripheral T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma Refractory Trial in United States (LB1901)
Active, not recruiting
- T-Cell Lymphoma
- +4 more
- LB1901
-
Rochester, Minnesota
- +3 more
Feb 15, 2022
Social Cognition in Longstanding Psychosis
Terminated
- Schizophrenia
- +4 more
-
Tucson, ArizonaUniversity of Arizona Department of Psychiatry
May 19, 2020
Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States
Recruiting
- Anaplastic Astrocytoma
- +6 more
- Biopsy
- +3 more
-
Birmingham, Alabama
- +62 more
Feb 2, 2023
Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV
Recruiting
- Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +28 more
- Cisplatin
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 16, 2022
ADHD NOS Trial in Cambridge (Strattera (atomoxetine))
Completed
- ADHD NOS
- Strattera (atomoxetine)
-
Cambridge, MassachusettsMassachusetts General Hospital
Aug 12, 2019
Schizophrenia, Schizoaffective Disorder, Bipolar Disorder With Psychotic Features Trial in Tucson (Group Cognitive Behavioral
Completed
- Schizophrenia
- +4 more
- Group Cognitive Behavioral Therapy
- Multifamily Group Psychoeducation
-
Tucson, ArizonaUniversity of Arizona Department of Psychiatry
May 19, 2020
Recent-Onset Psychosis, Schizophrenia, Schizoaffective Disorder Trial in Tucson (Multifamily Group Psychoeducation (MFG),
Completed
- Recent-Onset Psychosis
- +5 more
- Multifamily Group Psychoeducation (MFG)
- Cognitive Remediation (CR)
-
Tucson, ArizonaUniversity of Arizona
May 19, 2020
Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma Trial in Changchun (Rituximab,
Recruiting
- Peripheral T-Cell Lymphoma, Not Otherwise Specified
- Angioimmunoblastic T-cell Lymphoma
- Rituximab
- +4 more
-
Changchun, Jilin, ChinaThe First Bethune Hospital of Jilin University
Apr 7, 2023
A Study of People With CD30 Positive Lymphoma in China
Not yet recruiting
- Lymphoma
- (no location specified)
Aug 17, 2022
Salivary Glands Tumors Trial in Milan (Abiraterone acetate)
Completed
- Salivary Glands Tumors
- Abiraterone acetate
-
Milan, Lombardy, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Mar 1, 2021
Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy Trial in United States (Emavusertib, ibrutinib)
Recruiting
- Relapsed Hematologic Malignancy
- Refractory Hematologic Malignancy
-
Phoenix, Arizona
- +10 more
Feb 1, 2023
Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Tumor, Fibrolamellar Carcinoma Trial in Worldwide (drug, other,
Recruiting
- Childhood Hepatocellular Carcinoma
- +4 more
- Carboplatin
- +12 more
-
Birmingham, Alabama
- +201 more
Jan 30, 2023
Paraneoplastic Syndrome in Hepatocellular Carcinoma Patients
Recruiting
- Hepatocellular Carcinoma Patients
- Triphasic C.T abdomen and pelvis
-
Sohag, EgyptSohag University hospitals
Apr 26, 2023
Liver Cancer, Hepatocellular Carcinoma, Metastatic Colorectal Cancer Trial in Boston (Standard microcatheter, PEDD device)
Recruiting
- Liver Cancer
- +2 more
- Standard microcatheter
- PEDD device
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
May 17, 2022
Schizophrenia, Schizo Affective Disorder, Schizophreniform Disorders Trial in Glen Oaks (iTBS (Active), iTBS (Sham))
Recruiting
- Schizophrenia
- +3 more
- iTBS (Active)
- iTBS (Sham)
-
Glen Oaks, New YorkZucker Hillside Hospital
Nov 3, 2023